Stephen Honig, M.D.
Rheumatology Physician in New York, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,181 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Stephen Honig, M.D. reported a CMS MIPS final score of 84.5/100 - above the 83.1 national average - and filed 1,147 Medicare Part D claims in 2023.
- 84.5/100
- MIPS score · +1 vs avg
- 1K
- Part D claims, 2023
- 90%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Stephen Honig, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
85 45th percentile higher than 45% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Stephen Honig, M.D. sits
This provider among rheumatology physician peers
Across the 2,181 rheumatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Stephen Honig, M.D. writes more Part D claims than 29% of them and scores higher on MIPS quality than 48% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one rheumatology physician peer from a representative sample of 60; the gold marker is Stephen Honig, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Stephen Honig, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Stephen Honig, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Rheumatology Physician compares to other specialties among New York providers
Rheumatology Physician ranks #106 among New York's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the New York provider total, by primary NUCC taxonomy. The highlighted bar is Rheumatology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Stephen Honig, M.D.'s 2023 MIPS final score plotted against the Rheumatology Physician national average
- MIPS Final Score
- 84.5/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Rheumatology Physician) - 84.5/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Rheumatology Physician US NPIs
84.5/100 MIPS final score - 1.4 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Rheumatology Physician. Quality dim: 93.3. Cost dim: 54.9.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Stephen Honig, M.D. appears in the CMS NPPES registry as a Rheumatology Physician provider holding M.D. credentials at 301 E 17TH ST, New York, NY, 10003, with a listed phone of (212) 598-6367. NPI 1083653372 was issued on 06/05/2006.
Medicare Part D records for calendar year 2023 show 1,147 prescription claims written by this provider, covering 259 Medicare beneficiaries and totaling roughly $439K in drug spend, split 9% brand-name and 90% generic by claim count, with an opioid prescribing rate of 5.4%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84.5/100 for the 2023 performance year (Quality 93.3, Cost 54.9), compared with the national average of 83.1.
Rheumatology Physician is a mid-sized specialty nationwide, with 6,181 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1083653372 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/05/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Stephen Honig, M.D.'s current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1083653372 is the unique 10-digit identifier CMS uses to link Honig across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Stephen Honig, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$295
Largest payer
Radius Health, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Stephen Honig, M.D.. To verify Stephen Honig, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 90% generic, on 1,147 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,299
- Total Day Supply
- 67,252
- Brand vs Generic
- 9% brand / 90% generic
- Brand Drug Cost
- $395K
- Generic Drug Cost
- $44K
- Opioid Claims
- 62 (5.4% rate)
Patient Demographics
- Average Patient Age
- 74.4 years
- Avg HCC Risk Score
- 0.91
- Gender Split
- 89% female / 11% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Stephen Honig, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Alendronate Sodium
Alendronate Sodium
268 claims
- Raloxifene Hcl
Raloxifene Hcl
145 claims
- Ibandronate Sodium
Ibandronate Sodium
124 claims
- Risedronate Sodium
Risedronate Sodium
119 claims
- Allopurinol 44
Allopurinol
44 claims
- Tramadol Hcl 44
Tramadol Hcl
44 claims
- Tymlos 40
Tymlos
40 claims
- Leflunomide 28
Leflunomide
28 claims
| Drug | Claims |
|---|---|
| Alendronate Sodium | 268 |
| Raloxifene Hcl | 145 |
| Ibandronate Sodium | 124 |
| Risedronate Sodium | 119 |
| Allopurinol | 44 |
| Tramadol Hcl | 44 |
| Tymlos Abaloparatide | 40 |
| Leflunomide | 28 |
| Celecoxib | 27 |
| Methotrexate Methotrexate Sodium | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Stephen Honig, M.D. fits within the Rheumatology Physician landscape nationally.
Stephen Honig, M.D.'s 1,147 claims are below the specialty average of 2,054.
Nearby Rheumatology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Honig.
Compare Rheumatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Rheumatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is Stephen Honig, M.D.'s specialty? ▼
How much does Stephen Honig, M.D. prescribe under Medicare Part D? ▼
What is Stephen Honig, M.D.'s Medicare quality score? ▼
Where is Stephen Honig, M.D. located? ▼
What is Stephen Honig, M.D.'s NPI number? ▼
Does Stephen Honig, M.D. prescribe more brand-name or generic drugs? ▼
Does Stephen Honig, M.D. prescribe opioids? ▼
How many Rheumatology Physician providers are there in the US? ▼
What drugs does Stephen Honig, M.D. prescribe most often? ▼
Does Stephen Honig, M.D. accept Medicare? ▼
How can I verify Stephen Honig, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology